These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 914956)

  • 21. [Fluorescence assay and pharmacokinetics of vincamine in rats (author's transl)].
    Iven H; Siegers CP
    Arzneimittelforschung; 1977; 27(6a):1248-54. PubMed ID: 578449
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetic study of two pharmaceutical preparations containing alkaloid vincamine administered orally to human subjects.
    Millart H; Lamiable D; Houin G; Plat M; Choisy H; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):581-6. PubMed ID: 6654533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-performance liquid chromatographic determination of vinca-alkaloids in plasma and urine.
    De Smet M; Van Belle SJ; Storme GA; Massart DL
    J Chromatogr; 1985 Dec; 345(2):309-21. PubMed ID: 4086600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of vinca alkaloids in human plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.
    Ramírez J; Ogan K; Ratain MJ
    Cancer Chemother Pharmacol; 1997; 39(4):286-90. PubMed ID: 9025768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-performance liquid chromatography of eburnane alkaloids. I. Separation on reversed phases.
    Szepesi G; Gazdag M
    J Chromatogr; 1981 Jan; 204():341-8. PubMed ID: 7217263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Simultaneous determination of vinburnine and 6-hydroxyvinburnine in human plasma by high-performance liquid chromatography].
    Sado PA; Gibassier D; Leverge R
    J Chromatogr; 1988 Dec; 434(1):157-67. PubMed ID: 3243809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a sensitive enzyme immunoassay for the determination of vinpocetine in human plasma.
    Reck B; Dingler E; Lohmann A
    Arzneimittelforschung; 1992 Oct; 42(10):1171-4. PubMed ID: 1472136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Metabolism of vincamine in the rat].
    Viganò V; Paracchini S; Piacenza G; Pesce E
    Farmaco Sci; 1978 Aug; 33(8):583-94. PubMed ID: 744256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of multilayer vincamine dragees. Study of normal subjects].
    Lücker PW; Simon B; Talmont DM
    Arzneimittelforschung; 1978; 28(1):79-82. PubMed ID: 580205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromatographic analysis of Vinca alkaloids in human neoplastic tissues and host (mouse) tissues after injection in vivo or after incubation in vitro.
    Houghton JA; Torrance PM; Houghton PJ
    Anal Biochem; 1983 Oct; 134(2):450-4. PubMed ID: 6650830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of apovincaminic acid in serum by means of high-performance liquid chromatography.
    Kraus G; Schulz HU; Lohmann A
    J Chromatogr; 1992 Jan; 573(2):323-7. PubMed ID: 1601968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolic fate of 11-bromo[15-3H]vincamine in man.
    Mayo BC; Biggs SR; Hawkins DR; Chasseaud LF; Darragh A; Leaf FC
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):189-96. PubMed ID: 4085521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of apovincaminic acid in human plasma by high-performance liquid chromatography using solid-phase extraction and ultraviolet detection.
    Chen J; Cai J; Tao W; Mei N; Cao S; Jiang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):201-6. PubMed ID: 16321580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of vinca alkaloids in plasma and urine using ion-exchange chromatography on silica gel and fluorescence detection.
    Vendrig DE; Teeuwsen J; Holthuis JJ
    J Chromatogr; 1988 Dec; 434(1):145-55. PubMed ID: 2854133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug level monitoring: cytostatics.
    Eksborg S; Ehrsson H
    J Chromatogr; 1985 May; 340():31-72. PubMed ID: 2410436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid and simultaneous determination of five vinca alkaloids in Catharanthus roseus and human serum using trilinear component modeling of liquid chromatography-diode array detection data.
    Liu Z; Wu HL; Li Y; Gu HW; Yin XL; Xie LX; Yu RQ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():114-123. PubMed ID: 26321366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of vincamine on platelet respiration].
    Pesce E; Viganò V; Piacenza G
    Farmaco Prat; 1978 Aug; 33(8):343-50. PubMed ID: 748059
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics and metabolism of vincamine and related compounds.
    Vereczkey L
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):89-103. PubMed ID: 3899662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiac toxicity of vincamine: a seven cases report of ventricular arrhythmias by parenteral administration of vincamine (author's transl)].
    Dany F; Merle L; Goudoud JC; Liozon F; Blanc P; Bouvot JC; Nicot G; Dangoumau J
    Therapie; 1981; 36(1):55-64. PubMed ID: 7233373
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of vincamine and a vincamine-papaverine combination on erythrocyte flexibility in diabetic patients].
    Petruzzi E; Bucalossi A
    Minerva Cardioangiol; 1985 Nov; 33(11):671-3. PubMed ID: 4088469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.